Recombinant Medicines

The recombinant deoxyribonucleic acid molecules are often utilized in various ways useful in medicine and human biology. There are many applications for recombinant deoxyribonucleic acid technology. Cloned complementary DNA has been able to produce various human proteins in microorganisms. Insulin and somatotropin are extensively and successfully tested in humans and insulin has been licensed and made purchasable. Production of bacterial and viral antigens with recombinant deoxyribonucleic acid technology is probably going to supply safe and effective vaccines for a few disorders for which there are no available treatments. The cloned probes for the human α- and β-globin loci, for specific disease genes, like the Z allele of α-antitrypsin, and for random genomic sequences are proving useful for prenatally diagnosing human genetic disorders and preventing their clinical consequences.

Lysosomal proteins: Lysosomal proteins are difficult to supply recombinantly thanks to the amount and sort of post-translational modifications that they need (e.g. glycosylation). As a result, recombinant lysosomal proteins are usually produced in mammalian cells. Throgh Plant cell culture FDA approved glycosilated lysosmal protein-drug, and extra drug candidates. Recent studies have shown that it's going to be possible to supply recombinant lysosomal proteins with microorganisms like Escherichia coli and baker's yeast . Recombinant lysosomal proteins are used in both research and medical applications, like enzyme replacement therapy.

High Impact List of Articles

Relevant Topics in Medical Sciences